NFKBIA
(Nuclear Factor of kappa Light Polypeptide Gene Enhancer in B-Cells Inhibitor, alpha (NFKBIA))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
Attributs du produit
This is a synthetic peptide designed for use in combination with anti-NFKBIA antibody (Catalog #: P100940_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
NFKBIA
Reactivité: Humain, Souris, Porc, Mouton, Boeuf (Vache), Rat, Singe
Hôte: Synthetic
BP
Indications d'application
Each Investigator should determine their own optimal working dilution for specific applications.
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Concentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Conseil sur la manipulation
Avoid repeated freeze-thaw cycles.
Stock
-20 °C
Stockage commentaire
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Antigène
NFKBIA
(Nuclear Factor of kappa Light Polypeptide Gene Enhancer in B-Cells Inhibitor, alpha (NFKBIA))
Synonymes
IKBA Peptide, MAD-3 Peptide, NFKBI Peptide, AI462015 Peptide, Nfkbi Peptide, RL/IF-1 Peptide, ECI-6/IKBA Peptide, NFKBIA Peptide, ikbaB Peptide, wu:fb81f08 Peptide, zgc:56666 Peptide, zgc:77616 Peptide, ikbaA Peptide, wu:fj16a07 Peptide, zgc:85769 Peptide, NFKB inhibitor alpha Peptide, nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha Peptide, nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha b Peptide, nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha a Peptide, NFKBIA Peptide, Nfkbia Peptide, nfkbiab Peptide, nfkbiaa Peptide
Sujet
NFKB1 or NFKB2 is bound to REL, RELA, or RELB to form the NFKB complex. The NFKB complex is inhibited by I-kappa-B proteins (NFKBIA or NFKBIB), which inactivate NF-kappa-B by trapping it in the cytoplasm. Phosphorylation of serine residues on the I-kappa-B proteins by kinases (IKBKA, or IKBKB) marks them for destruction via the ubiquitination pathway, thereby allowing activation of the NF-kappa-B complex. Activated NFKB complex translocates into the nucleus and binds DNA at kappa-B-binding motifs such as 5-prime GGGRNNYYCC 3-prime or 5-prime HGGARNYYCC 3-prime (where H is A, C, or T, R is an A or G purine, and Y is a C or T pyrimidine).
Alias Symbols: IKBA, MAD-3, NFKBI
Protein Interaction Partner: ARRB1,ARRB2,BTRC,CHUK,CHUK,COMMD1,DYNLL1,ERC1,HDAC1,HDAC3,IKBKB,IKBKB,IKBKB,LCK,NFKB1,RELA,RELA,ARRB1,ARRB2,BTRC,CAPN1,CAPN2,CDC34,CHUK,COMMD1,COPS8,CSNK2A1,CUL1,DYNLL1,EIF2AK2,FBXW11,G3BP2,HDAC1,HDAC3,HNRNPA1,HOXA9,HOXB7,HSPB1,IKBKAP,IKBKB,IKBKE,IKBKG,JAK2,LCK,MAP3K2,MAP3K3,MCM5,MCM7,MED19,NCOR2,NFKB1,NFKB2,NFKBIB,NKIRAS1,NKIRAS2,PIK3R1,POM121,PRKCI,PTPN1,PTPN13,REL,RELA,RPS6KA1,SKP1,SLC25A4,SLC25A5,SRC,SUMO1,SUMO4,TBK1,TNFSF11,TP53,TUBA1B,UBE2D2,UBE2D3,UBE2E3,VCP,AURKA,BARD1,BTRC,CAPN1,CHUK,COMMD1,DYNLL1,FBXW11,G3BP2,HNRNPA1,HOXB7,IKBKAP,IKBKB,LYL1,MAP3K14,MED19,NCOR2,NFKB1,PIK3R1,PIR,POM121,PTPN13,REL,RELA,RPS6KA1,SUMO4,TP53,UBC,UBE2D1,UBE2E3,VCP